IntelliPharmaCeutics (QB) Stock Price - IPCIF

0.165
0.0084 (5.36%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
IntelliPharmaCeutics International Inc (QB) IPCIF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.0084 5.36% 0.165 0.1511 0.1718 0.1669 0.1566 16:30:02
Bid Price Ask Price Spread Spread % News
0.1089 0.2579 0.149 57.77% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
25 41,937 $ 0.166153 $ 6,968 403,850 0.086 - 1.50
Last Trade Time Type Quantity Stock Price Currency
15:56:28 2,269 $ 0.165 USD

IntelliPharmaCeutics (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.91M 23.68M $ -13.75M - - 21.49M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
224.48k $ - 0.00% - -

more financials information »

IntelliPharmaCeutics (QB) News

Loading Messages....

Latest IPCIF Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IPCIF Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.150.17560.150.169199141,7040.01510.0%
1 Month0.2030.2030.14930.167382373,715-0.038-18.72%
3 Months0.141.500.12610.4954959435,8330.02517.86%
6 Months0.22481.500.0860.4246746240,153-0.0598-26.6%
1 Year0.16561.500.0860.37072186,658-0.0006-0.36%
3 Years0.16561.500.0860.37072186,658-0.0006-0.36%
5 Years0.16561.500.0860.37072186,658-0.0006-0.36%

IntelliPharmaCeutics (QB) Description

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company's patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a wide range of existing and new pharmaceuticals. Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received FDA approval) in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company's abuse-deterrent oxycodone hydrochloride extended release formulation ("Oxycodone ER") based on its proprietary nPODDDS novel Point Of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules).


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.